Stanislovas S. Jankauskas

SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients

Pasquale Mone, Fahimeh Varzideh, Stanislovas S. Jankauskas et al. · Hypertension · 2022 · 197 citations · Full text

Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion

Egor Y. Plotnikov, Stanislovas S. Jankauskas, Irina B. Pevzner et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2010 · 118 citations · Full text

Inflammation, Mitochondria-targeted Antioxidants, Biochemistry +9

Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes

Pasquale Mone, Angela Lombardi, Urna Kansakar et al. · Journal of Pharmacology and Experimental Therapeutics · 2022 · 96 citations · Full text

COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells

Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu et al. · Antioxidants · 2023 · 82 citations · Full text

Inflammation, Metabolic Syndrome, Endothelial Cells +15

Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)

Pasquale Mone, Angela Lombardi, Luigi Salemme et al. · Diabetes Care · 2022 · 79 citations · Full text